Dec 17, 2019 Robert Fortner, The Scientist.
Quote:” The new vaccine, called nOPV2, might conclusively end the outbreaks, caused by the live virus in the vaccine reverting to a virulent form. But expedited approval means skipping the real-world testing of large clinical trials.” Instead, key questions about the vaccine’s effectiveness will be answered in the field.“
Nederlands
Lees verder “Serious! New Oral Polio Vaccine to Bypass Key Clinical Trials Health officials are rushing a genetically engineered product into the field to counter uncontained outbreaks of vaccine-derived polio.”